KPIs & Operating Metrics(New)
Balance Sheet
Accumulated ExpensesCash & Current InvestmentsCash & EquivalentsCash Due from BankCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetLoans - NetLong-Term InvestmentsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsSecurities - Held-to-maturitySecurities - TradableShort term DebtTotal DebtTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bank of N.T. Butterfield & Son (NTB) Cash & Equivalents (2016 - 2025)

Bank of N.T. Butterfield & Son has reported Cash & Equivalents over the past 11 years, most recently at $3.5 billion for Q3 2025.

  • Quarterly Cash & Equivalents fell 2.74% to $3.5 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $3.5 billion through Sep 2025, down 2.74% year-over-year, with the annual reading at $1.6 billion for FY2023, 5.88% down from the prior year.
  • Cash & Equivalents was $3.5 billion for Q3 2025 at Bank of N.T. Butterfield & Son, down from $3.6 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $3.6 billion in Q3 2024 and troughed at $1.3 billion in Q2 2022.
  • The 5-year median for Cash & Equivalents is $1.9 billion (2022), against an average of $2.3 billion.
  • Year-over-year, Cash & Equivalents crashed 59.59% in 2022 and then skyrocketed 72.36% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $1.6 billion in 2021, then increased by 7.56% to $1.7 billion in 2022, then decreased by 5.88% to $1.6 billion in 2023, then skyrocketed by 116.97% to $3.6 billion in 2024, then fell by 2.74% to $3.5 billion in 2025.
  • Per Business Quant, the three most recent readings for NTB's Cash & Equivalents are $3.5 billion (Q3 2025), $3.6 billion (Q3 2024), and $2.4 billion (Q2 2024).